Patient & Survivor Care
News
FDA Approves Epcoritamab for R/R Follicular Lymphoma
The approval was based on the single-arm EPCORE NHL-1 trial in 127 patients who had received at least two lines of systemic therapy.
Conference Coverage
MUC-1 vaccine associated with notable overall survival rates in breast cancer
Patients with HER2-negative early breast cancer receive preoperative standard of care neoadjuvant treatment with or without tecemotide, in new...
Conference Coverage
Thermal Ablation Tops Surgery for Small CRC Liver Mets
The benefit of thermal ablation was so substantial that the trial was stopped early.
Conference Coverage
Neurofilament Light Chain Detects Early Chemotherapy-Related Neurotoxicity
“Nfl after a single cycle could detect axonal degeneration,” says the lead author of new research.
Conference Coverage
Experts Focus on Quality-of-Life Data in Prostate Cancer
Trials presented at ASCO explore the effects of treatment suspension or intensification on health-related QoL and interventions to manage side...
Conference Coverage
ESOPEC: FLOT Bests CROSS in Resectable Esophageal Cancer
Study results settle a long-standing debate about whether chemotherapy with FLOT before and after surgery, or neoadjuvant radiation plus CROSS...
From the Journals
Liver Resection Beats Out Alternatives in Early Multinodular HCC
Researchers compare the efficacy of liver resection, percutaneous radiofrequency ablation, and TACE in patients with early multinodular HCC.
Conference Coverage
Platinum Add-On Improves Survival in Early TNBC
Trial outcomes provide strong evidence for incorporating carboplatin into both the neoadjuvant and adjuvant settings in patients with early-stage...
Conference Coverage
Should ctDNA guide clinical decisions in GI cancers?
Data are maturing for colon cancer and emerging for pancreatic cancer, but experts say more work needs to be done.
Conference Coverage
Inavolisib Added to Standard Tx Shows Sustained Benefit in Advanced BC
An expanded analysis of the INAVO120 trial looks at time from randomization to end of next-line treatment, time to first chemotherapy, and patient...
Conference Coverage
One Patient Changed This Oncologist’s View of Hope. Here’s How.
“How we think about hope directly influences patient care,” according to a professor of clinical medicine at Weill Cornell Medicine in New York...